Myc (Japanese Wikipedia)

Analysis of information sources in references of the Wikipedia article "Myc" in Japanese language version.

Last modified: 19:36:19, 29 March 2026 (UTC)

Ref.Un. Ref.Website

Global rank Japanese rank

5^th place

11^th place

2^nd place

3^rd place

1514adsabs.harvard.edu

14^th place

60^th place

4^th place

12^th place

38^th place

68^th place

1,380^th place

9,870^th place

11myscience.org.uk

low place

low place

4,422^nd place

7,982^nd place

adsabs.harvard.edu (Global: 14^th place; Japanese: 60^th place)

ui.adsabs.harvard.edu

“Sequence analysis of the Myc oncogene involved in the t(8;14)(q24;q11) chromosome translocation in a human leukemia T-cell line indicates that putative regulatory regions are not altered”. Proceedings of the National Academy of Sciences of the United States of America 85 (9): 3052–6. (May 1988). Bibcode:1988PNAS...85.3052F. doi:10.1073/pnas.85.9.3052. PMC 280141. PMID 2834731.
“Non-transcriptional control of DNA replication by c-Myc”. Nature 448 (7152): 445–51. (July 2007). Bibcode:2007Natur.448..445D. doi:10.1038/nature05953. PMID 17597761.
“Global regulation of nucleotide biosynthetic genes by c-Myc”. PLOS One 3 (7): e2722. (July 2008). Bibcode:2008PLoSO...3.2722L. doi:10.1371/journal.pone.0002722. PMC 2444028. PMID 18628958.
“Myc-driven endogenous cell competition in the early mammalian embryo”. Nature 500 (7460): 39–44. (August 2013). Bibcode:2013Natur.500...39C. doi:10.1038/nature12389. PMID 23842495.
“A SUMOylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis”. Science 335 (6066): 348–53. (January 2012). Bibcode:2012Sci...335..348K. doi:10.1126/science.1212728. PMC 4059214. PMID 22157079.
“Identification of druggable cancer driver genes amplified across TCGA datasets”. PLOS One 9 (5): e98293. (2014). Bibcode:2014PLoSO...998293C. doi:10.1371/journal.pone.0098293. PMC 4038530. PMID 24874471.
“Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes”. Nature 304 (5927): 596–602. (1983). Bibcode:1983Natur.304..596L. doi:10.1038/304596a0. PMID 6308472.
“Regulation of MYC expression and differential JQ1 sensitivity in cancer cells”. PLOS One 9 (1): e87003. (2014). Bibcode:2014PLoSO...987003F. doi:10.1371/journal.pone.0087003. PMC 3900694. PMID 24466310.
“Direct role for Myc in transcription initiation mediated by interactions with TFII-I”. Nature 365 (6444): 359–61. (September 1993). Bibcode:1993Natur.365..359R. doi:10.1038/365359a0. PMID 8377829.
“Mitogen-activated protein kinase kinase 7 is an activator of the c-Jun NH2-terminal kinase”. Proceedings of the National Academy of Sciences of the United States of America 94 (14): 7337–42. (July 1997). Bibcode:1997PNAS...94.7337T. doi:10.1073/pnas.94.14.7337. PMC 23822. PMID 9207092.
“Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc”. Science 251 (4998): 1211–7. (March 1991). Bibcode:1991Sci...251.1211B. doi:10.1126/science.2006410. PMID 2006410.
“JLP: A scaffolding protein that tethers JNK/p38MAPK signaling modules and transcription factors”. Proceedings of the National Academy of Sciences of the United States of America 99 (22): 14189–94. (October 2002). Bibcode:2002PNAS...9914189L. doi:10.1073/pnas.232310199. PMC 137859. PMID 12391307.
“Identification of a large Myc-binding protein that contains RCC1-like repeats”. Proceedings of the National Academy of Sciences of the United States of America 95 (16): 9172–7. (August 1998). Bibcode:1998PNAS...95.9172G. doi:10.1073/pnas.95.16.9172. PMC 21311. PMID 9689053.
“Inhibition of transcriptional regulator Yin-Yang-1 by association with c-Myc”. Science 262 (5141): 1889–92. (December 1993). Bibcode:1993Sci...262.1889S. doi:10.1126/science.8266081. PMID 8266081.

doi.org (Global: 2^nd place; Japanese: 3^rd place)

“Sequence analysis of the Myc oncogene involved in the t(8;14)(q24;q11) chromosome translocation in a human leukemia T-cell line indicates that putative regulatory regions are not altered”. Proceedings of the National Academy of Sciences of the United States of America 85 (9): 3052–6. (May 1988). Bibcode:1988PNAS...85.3052F. doi:10.1073/pnas.85.9.3052. PMC 280141. PMID 2834731.
“Therapeutic Inhibition of Myc in Cancer. Structural Bases and Computer-Aided Drug Discovery Approaches”. International Journal of Molecular Sciences 20 (1): 120. (December 2018). doi:10.3390/ijms20010120. PMC 6337544. PMID 30597997.
“Drugging the 'undruggable' cancer targets”. Nature Reviews. Cancer 17 (8): 502–508. (August 2017). doi:10.1038/nrc.2017.36. PMC 5945194. PMID 28643779.
“Pluripotency redux--advances in stem-cell research”. The New England Journal of Medicine 357 (15): 1469–72. (October 2007). doi:10.1056/NEJMp078126. PMID 17928593.
“N-Myc regulates a widespread euchromatic program in the human genome partially independent of its role as a classical transcription factor”. Cancer Research 68 (23): 9654–62. (December 2008). doi:10.1158/0008-5472.CAN-08-1961. PMC 2637654. PMID 19047142.
Wasylishen, Amanda R.; Penn, Linda Z. (2010-06). “Myc: the beauty and the beast”. Genes & Cancer 1 (6): 532–541. doi:10.1177/1947601910378024. ISSN 1947-6027. PMC 3092215. PMID 21779457.
Lüscher, B.; Larsson, L. G. (1999-05-13). “The basic region/helix-loop-helix/leucine zipper domain of Myc proto-oncoproteins: function and regulation”. Oncogene 18 (19): 2955–2966. doi:10.1038/sj.onc.1202750. ISSN 0950-9232. PMID 10378692.
Stoneley, M.; Subkhankulova, T.; Le Quesne, J. P.; Coldwell, M. J.; Jopling, C. L.; Belsham, G. J.; Willis, A. E. (2000-02-01). “Analysis of the c-myc IRES; a potential role for cell-type specific trans-acting factors and the nuclear compartment”. Nucleic Acids Research 28 (3): 687–694. doi:10.1093/nar/28.3.687. ISSN 1362-4962. PMC 102558. PMID 10637319.
“MYC and transcription elongation”. Cold Spring Harbor Perspectives in Medicine 4 (1): a020990. (January 2014). doi:10.1101/cshperspect.a020990. PMC 3869279. PMID 24384817.
“Non-transcriptional control of DNA replication by c-Myc”. Nature 448 (7152): 445–51. (July 2007). Bibcode:2007Natur.448..445D. doi:10.1038/nature05953. PMID 17597761.
“Cell-cycle control of c-myc but not c-ras expression is lost following chemical transformation”. Cell 36 (2): 241–7. (1984). doi:10.1016/0092-8674(84)90217-4. PMID 6692471.
“Global regulation of nucleotide biosynthetic genes by c-Myc”. PLOS One 3 (7): e2722. (July 2008). Bibcode:2008PLoSO...3.2722L. doi:10.1371/journal.pone.0002722. PMC 2444028. PMID 18628958.
“Direct role of nucleotide metabolism in C-MYC-dependent proliferation of melanoma cells”. Cell Cycle 7 (15): 2392–400. (August 2008). doi:10.4161/cc.6390. PMC 3744895. PMID 18677108.
“The Interplay between Myc and CTP Synthase in Drosophila”. PLOS Genetics 12 (2): e1005867. (February 2016). doi:10.1371/journal.pgen.1005867. PMC 4759343. PMID 26889675.
“Myc-driven endogenous cell competition in the early mammalian embryo”. Nature 500 (7460): 39–44. (August 2013). Bibcode:2013Natur.500...39C. doi:10.1038/nature12389. PMID 23842495.
“Analysis of C-MYC function in normal cells via conditional gene-targeted mutation”. Immunity 14 (1): 45–55. (January 2001). doi:10.1016/S1074-7613(01)00088-7. PMID 11163229.
“Myc-nick: a cytoplasmic cleavage product of Myc that promotes alpha-tubulin acetylation and cell differentiation”. Cell 142 (3): 480–93. (August 2010). doi:10.1016/j.cell.2010.06.037. PMC 2923036. PMID 20691906.
“c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells”. Cell 151 (1): 68–79. (September 2012). doi:10.1016/j.cell.2012.08.033. PMC 3471363. PMID 23021216.
“A SUMOylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis”. Science 335 (6066): 348–53. (January 2012). Bibcode:2012Sci...335..348K. doi:10.1126/science.1212728. PMC 4059214. PMID 22157079.
“Comprehensive genomic profiling of epithelial ovarian cancer by next generation sequencing-based diagnostic assay reveals new routes to targeted therapies”. Gynecologic Oncology 130 (3): 554–9. (September 2013). doi:10.1016/j.ygyno.2013.06.019. PMID 23791828.
“Identification of druggable cancer driver genes amplified across TCGA datasets”. PLOS One 9 (5): e98293. (2014). Bibcode:2014PLoSO...998293C. doi:10.1371/journal.pone.0098293. PMC 4038530. PMID 24874471.
“Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes”. Nature 304 (5927): 596–602. (1983). Bibcode:1983Natur.304..596L. doi:10.1038/304596a0. PMID 6308472.
“Tumor induction by ras and myc oncogenes in fetal and neonatal brain: modulating effects of developmental stage and retroviral dose”. Acta Neuropathologica 86 (5): 456–65. (1993). doi:10.1007/bf00228580. PMID 8310796.
“Regulation of MYC expression and differential JQ1 sensitivity in cancer cells”. PLOS One 9 (1): e87003. (2014). Bibcode:2014PLoSO...987003F. doi:10.1371/journal.pone.0087003. PMC 3900694. PMID 24466310.
“The mechanisms behind the therapeutic activity of BET bromodomain inhibition”. Molecular Cell 54 (5): 728–36. (June 2014). doi:10.1016/j.molcel.2014.05.016. PMC 4236231. PMID 24905006.
“BET bromodomain inhibition as a therapeutic strategy to target c-Myc”. Cell 146 (6): 904–17. (September 2011). doi:10.1016/j.cell.2011.08.017. PMC 3187920. PMID 21889194.
“Drosophila myc regulates organ size by inducing cell competition”. Cell 117 (1): 107–16. (April 2004). doi:10.1016/S0092-8674(04)00214-4. PMID 15066286.
“Drosophila dMyc is required for ovary cell growth and endoreplication”. Development 131 (4): 775–86. (February 2004). doi:10.1242/dev.00932. PMID 14724122.
“Drosophila myc regulates cellular growth during development”. Cell 98 (6): 779–90. (September 1999). doi:10.1016/S0092-8674(00)81512-3. PMID 10499795.
Harris, A. W.; Pinkert, C. A.; Crawford, M.; Langdon, W. Y.; Brinster, R. L.; Adams, J. M. (1988-02-01). “The E mu-myc transgenic mouse. A model for high-incidence spontaneous lymphoma and leukemia of early B cells”. The Journal of Experimental Medicine 167 (2): 353–371. doi:10.1084/jem.167.2.353. ISSN 0022-1007. PMC 2188841. PMID 3258007.
Hofmann, Jeffrey W.; Zhao, Xiaoai; De Cecco, Marco; Peterson, Abigail L.; Pagliaroli, Luca; Manivannan, Jayameenakshi; Hubbard, Gene B.; Ikeno, Yuji et al. (2015-01-29). “Reduced expression of MYC increases longevity and enhances healthspan”. Cell 160 (3): 477–488. doi:10.1016/j.cell.2014.12.016. ISSN 1097-4172. PMC 4624921. PMID 25619689.
Abraham, Sheela A.; Hopcroft, Lisa E. M.; Carrick, Emma; Drotar, Mark E.; Dunn, Karen; Williamson, Andrew J. K.; Korfi, Koorosh; Baquero, Pablo et al. (06 16, 2016). “Dual targeting of p53 and c-MYC selectively eliminates leukaemic stem cells”. Nature 534 (7607): 341–346. doi:10.1038/nature18288. ISSN 1476-4687. PMC 4913876. PMID 27281222.
Takahaski, Kazutoshi; Yamanaka, Shinya (17 Feb 2016). “A decade of transcription factor-mediated reprogramming to pluripotency”. Nature Reviews. Molecular Cell Biology 17 (3): 183–193. doi:10.1038/nrm.2016.8. PMID 26883003.
“BAF53 forms distinct nuclear complexes and functions as a critical c-Myc-interacting nuclear cofactor for oncogenic transformation”. Molecular and Cellular Biology 22 (5): 1307–16. (March 2002). doi:10.1128/mcb.22.5.1307-1316.2002. PMC 134713. PMID 11839798.
“A novel tricomplex of BRCA1, Nmi, and c-Myc inhibits c-Myc-induced human telomerase reverse transcriptase gene (hTERT) promoter activity in breast cancer”. The Journal of Biological Chemistry 277 (23): 20965–73. (June 2002). doi:10.1074/jbc.M112231200. PMID 11916966.
“BRCA1 inhibition of telomerase activity in cultured cells”. Molecular and Cellular Biology 23 (23): 8668–90. (December 2003). doi:10.1128/mcb.23.23.8668-8690.2003. PMC 262673. PMID 14612409.
“Inhibition of human telomerase reverse transcriptase gene expression by BRCA1 in human ovarian cancer cells”. Biochemical and Biophysical Research Communications 303 (1): 130–6. (March 2003). doi:10.1016/s0006-291x(03)00318-8. PMID 12646176.
“BRCA1 binds c-Myc and inhibits its transcriptional and transforming activity in cells”. Oncogene 17 (15): 1939–48. (October 1998). doi:10.1038/sj.onc.1202403. PMID 9788437.
“Tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone promotes functional cooperation of Bcl2 and c-Myc through phosphorylation in regulating cell survival and proliferation”. The Journal of Biological Chemistry 279 (38): 40209–19. (September 2004). doi:10.1074/jbc.M404056200. PMID 15210690.
“c-Myc recruits P-TEFb for transcription, cellular proliferation and apoptosis”. Oncogene 22 (36): 5707–11. (August 2003). doi:10.1038/sj.onc.1206800. PMID 12944920.
“BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors”. Journal of Proteomics 118 (12): 95–111. (April 2015). doi:10.1016/j.jprot.2014.09.029. PMID 25452129.
“Myc represses transcription through recruitment of DNA methyltransferase corepressor”. The EMBO Journal 24 (2): 336–46. (January 2005). doi:10.1038/sj.emboj.7600509. PMC 545804. PMID 15616584.
“The p400 complex is an essential E1A transformation target”. Cell 106 (3): 297–307. (August 2001). doi:10.1016/s0092-8674(01)00450-0. PMID 11509179.
“Direct role for Myc in transcription initiation mediated by interactions with TFII-I”. Nature 365 (6444): 359–61. (September 1993). Bibcode:1993Natur.365..359R. doi:10.1038/365359a0. PMID 8377829.
“MYC recruits the TIP60 histone acetyltransferase complex to chromatin”. EMBO Reports 4 (6): 575–80. (June 2003). doi:10.1038/sj.embor.embor861. PMC 1319201. PMID 12776177.
“Widespread microRNA repression by Myc contributes to tumorigenesis”. Nature Genetics 40 (1): 43–50. (January 2008). doi:10.1038/ng.2007.30. PMC 2628762. PMID 18066065.
“Prediction and preliminary validation of oncogene regulation by miRNAs”. BMC Molecular Biology 8: 79. (2007). doi:10.1186/1471-2199-8-79. PMC 2096627. PMID 17877811.
“CRD-BP/IMP1 expression characterizes cord blood CD34+ stem cells and affects c-myc and IGF-II expression in MCF-7 cancer cells”. The Journal of Biological Chemistry 280 (20): 20086–93. (May 2005). doi:10.1074/jbc.M410036200. PMID 15769738.
“MAP kinase binds to the NH2-terminal activation domain of c-Myc”. FEBS Letters 353 (3): 281–5. (October 1994). doi:10.1016/0014-5793(94)01052-8. PMID 7957875.
“Mitogen-activated protein kinase kinase 7 is an activator of the c-Jun NH2-terminal kinase”. Proceedings of the National Academy of Sciences of the United States of America 94 (14): 7337–42. (July 1997). Bibcode:1997PNAS...94.7337T. doi:10.1073/pnas.94.14.7337. PMC 23822. PMID 9207092.
“Regulation of c-Myc through phosphorylation at Ser-62 and Ser-71 by c-Jun N-terminal kinase”. The Journal of Biological Chemistry 274 (46): 32580–7. (November 1999). doi:10.1074/jbc.274.46.32580. PMID 10551811.
“Large-scale mapping of human protein-protein interactions by mass spectrometry”. Molecular Systems Biology 3: 89. (2007). doi:10.1038/msb4100134. PMC 1847948. PMID 17353931.
“The essential cofactor TRRAP recruits the histone acetyltransferase hGCN5 to c-Myc”. Molecular and Cellular Biology 20 (2): 556–62. (January 2000). doi:10.1128/mcb.20.2.556-562.2000. PMC 85131. PMID 10611234.
“The novel ATM-related protein TRRAP is an essential cofactor for the c-Myc and E2F oncoproteins”. Cell 94 (3): 363–74. (August 1998). doi:10.1016/s0092-8674(00)81479-8. PMID 9708738.
“c-MYC interacts with INI1/hSNF5 and requires the SWI/SNF complex for transactivation function”. Nature Genetics 22 (1): 102–5. (May 1999). doi:10.1038/8811. PMID 10319872.
“Interactions of the DNA mismatch repair proteins MLH1 and MSH2 with c-MYC and MAX”. Oncogene 22 (6): 819–25. (February 2003). doi:10.1038/sj.onc.1206252. PMID 12584560.
“Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc”. Science 251 (4998): 1211–7. (March 1991). Bibcode:1991Sci...251.1211B. doi:10.1126/science.2006410. PMID 2006410.
“JLP: A scaffolding protein that tethers JNK/p38MAPK signaling modules and transcription factors”. Proceedings of the National Academy of Sciences of the United States of America 99 (22): 14189–94. (October 2002). Bibcode:2002PNAS...9914189L. doi:10.1073/pnas.232310199. PMC 137859. PMID 12391307.
“Mlx, a novel Max-like BHLHZip protein that interacts with the Max network of transcription factors”. The Journal of Biological Chemistry 274 (51): 36344–50. (December 1999). doi:10.1074/jbc.274.51.36344. PMID 10593926.
“Mmip1: a novel leucine zipper protein that reverses the suppressive effects of Mad family members on c-myc”. Oncogene 16 (9): 1149–59. (March 1998). doi:10.1038/sj.onc.1201634. PMID 9528857.
“Rox, a novel bHLHZip protein expressed in quiescent cells that heterodimerizes with Max, binds a non-canonical E box and acts as a transcriptional repressor”. The EMBO Journal 16 (10): 2892–906. (May 1997). doi:10.1093/emboj/16.10.2892. PMC 1169897. PMID 9184233.
“X-ray structures of Myc-Max and Mad-Max recognizing DNA. Molecular bases of regulation by proto-oncogenic transcription factors”. Cell 112 (2): 193–205. (January 2003). doi:10.1016/s0092-8674(02)01284-9. PMID 12553908.
“Differential effects of the widely expressed dMax splice variant of Max on E-box vs initiator element-mediated regulation by c-Myc”. Oncogene 18 (15): 2489–98. (April 1999). doi:10.1038/sj.onc.1202611. PMID 10229200.
“Mlx, a new Max-like bHLHZip family member: the center stage of a novel transcription factors regulatory pathway?”. Oncogene 19 (29): 3266–77. (July 2000). doi:10.1038/sj.onc.1203634. PMID 10918583.
“Identification of a large Myc-binding protein that contains RCC1-like repeats”. Proceedings of the National Academy of Sciences of the United States of America 95 (16): 9172–7. (August 1998). Bibcode:1998PNAS...95.9172G. doi:10.1073/pnas.95.16.9172. PMC 21311. PMID 9689053.
“AMY-1, a novel C-MYC binding protein that stimulates transcription activity of C-MYC”. Genes to Cells 3 (8): 549–65. (August 1998). doi:10.1046/j.1365-2443.1998.00206.x. PMID 9797456.
“Cell cycle-dependent switch of up-and down-regulation of human hsp70 gene expression by interaction between c-Myc and CBF/NF-Y”. The Journal of Biological Chemistry 274 (34): 24270–9. (August 1999). doi:10.1074/jbc.274.34.24270. PMID 10446203.
“p73 Interacts with c-Myc to regulate Y-box-binding protein-1 expression”. The Journal of Biological Chemistry 277 (35): 31694–702. (August 2002). doi:10.1074/jbc.M200266200. PMID 12080043.
“c-Myc transformation domain recruits the human STAGA complex and requires TRRAP and GCN5 acetylase activity for transcription activation”. The Journal of Biological Chemistry 278 (22): 20405–12. (May 2003). doi:10.1074/jbc.M211795200. PMC 4031917. PMID 12660246.
“MM-1, a novel c-Myc-associating protein that represses transcriptional activity of c-Myc”. The Journal of Biological Chemistry 273 (45): 29794–800. (November 1998). doi:10.1074/jbc.273.45.29794. PMID 9792694.
“MM-1, a c-Myc-binding protein, is a candidate for a tumor suppressor in leukemia/lymphoma and tongue cancer”. The Journal of Biological Chemistry 276 (48): 45137–44. (November 2001). doi:10.1074/jbc.M106127200. PMID 11567024.
“Direct interaction of c-Myc with Smad2 and Smad3 to inhibit TGF-beta-mediated induction of the CDK inhibitor p15(Ink4B)”. Molecular Cell 9 (1): 133–43. (January 2002). doi:10.1016/s1097-2765(01)00430-0. PMID 11804592.
“Guanine nucleotide exchange factor, Tiam1, directly binds to c-Myc and interferes with c-Myc-mediated apoptosis in rat-1 fibroblasts”. The Journal of Biological Chemistry 278 (7): 5132–40. (February 2003). doi:10.1074/jbc.M206733200. PMID 12446731.
“Transcriptional activation by Myc is under negative control by the transcription factor AP-2”. The EMBO Journal 14 (7): 1508–19. (April 1995). doi:10.1002/j.1460-2075.1995.tb07137.x. PMC 398238. PMID 7729426.
“Interaction with WDR5 promotes target gene recognition and tumorigenesis by MYC”. Molecular Cell 58 (3): 440–52. (May 2015). doi:10.1016/j.molcel.2015.02.028. PMC 4427524. PMID 25818646.
“Inhibition of transcriptional regulator Yin-Yang-1 by association with c-Myc”. Science 262 (5141): 1889–92. (December 1993). Bibcode:1993Sci...262.1889S. doi:10.1126/science.8266081. PMID 8266081.
“Repression of p15INK4b expression by Myc through association with Miz-1”. Nature Cell Biology 3 (4): 392–9. (April 2001). doi:10.1038/35070076. PMID 11283613.
“An alternative pathway for gene regulation by Myc”. The EMBO Journal 16 (18): 5672–86. (September 1997). doi:10.1093/emboj/16.18.5672. PMC 1170199. PMID 9312026.

ebi.ac.uk (Global: 4,422^nd place; Japanese: 7,982^nd place)

“PSICQUIC View”. ebi.ac.uk. 2019年5月2日閲覧。

myscience.org.uk (Global: low place; Japanese: low place)

“Scientists identify drugs to target 'Achilles heel' of Chronic Myeloid Leukaemia cells”. myScience (2016年6月8日). 2016年6月9日閲覧。

nih.gov (Global: 5^th place; Japanese: 11^th place)

pubmed.ncbi.nlm.nih.gov

“Sequence analysis of the Myc oncogene involved in the t(8;14)(q24;q11) chromosome translocation in a human leukemia T-cell line indicates that putative regulatory regions are not altered”. Proceedings of the National Academy of Sciences of the United States of America 85 (9): 3052–6. (May 1988). Bibcode:1988PNAS...85.3052F. doi:10.1073/pnas.85.9.3052. PMC 280141. PMID 2834731.
“Therapeutic Inhibition of Myc in Cancer. Structural Bases and Computer-Aided Drug Discovery Approaches”. International Journal of Molecular Sciences 20 (1): 120. (December 2018). doi:10.3390/ijms20010120. PMC 6337544. PMID 30597997.
“Drugging the 'undruggable' cancer targets”. Nature Reviews. Cancer 17 (8): 502–508. (August 2017). doi:10.1038/nrc.2017.36. PMC 5945194. PMID 28643779.
“Pluripotency redux--advances in stem-cell research”. The New England Journal of Medicine 357 (15): 1469–72. (October 2007). doi:10.1056/NEJMp078126. PMID 17928593.
“N-Myc regulates a widespread euchromatic program in the human genome partially independent of its role as a classical transcription factor”. Cancer Research 68 (23): 9654–62. (December 2008). doi:10.1158/0008-5472.CAN-08-1961. PMC 2637654. PMID 19047142.
Wasylishen, Amanda R.; Penn, Linda Z. (2010-06). “Myc: the beauty and the beast”. Genes & Cancer 1 (6): 532–541. doi:10.1177/1947601910378024. ISSN 1947-6027. PMC 3092215. PMID 21779457.
Lüscher, B.; Larsson, L. G. (1999-05-13). “The basic region/helix-loop-helix/leucine zipper domain of Myc proto-oncoproteins: function and regulation”. Oncogene 18 (19): 2955–2966. doi:10.1038/sj.onc.1202750. ISSN 0950-9232. PMID 10378692.
Stoneley, M.; Subkhankulova, T.; Le Quesne, J. P.; Coldwell, M. J.; Jopling, C. L.; Belsham, G. J.; Willis, A. E. (2000-02-01). “Analysis of the c-myc IRES; a potential role for cell-type specific trans-acting factors and the nuclear compartment”. Nucleic Acids Research 28 (3): 687–694. doi:10.1093/nar/28.3.687. ISSN 1362-4962. PMC 102558. PMID 10637319.
“MYC and transcription elongation”. Cold Spring Harbor Perspectives in Medicine 4 (1): a020990. (January 2014). doi:10.1101/cshperspect.a020990. PMC 3869279. PMID 24384817.
“Non-transcriptional control of DNA replication by c-Myc”. Nature 448 (7152): 445–51. (July 2007). Bibcode:2007Natur.448..445D. doi:10.1038/nature05953. PMID 17597761.
“Stimulation of methotrexate resistance and dihydrofolate reductase gene amplification by c-myc”. Oncogene 6 (8): 1453–7. (August 1991). PMID 1886715.
“Cell-cycle control of c-myc but not c-ras expression is lost following chemical transformation”. Cell 36 (2): 241–7. (1984). doi:10.1016/0092-8674(84)90217-4. PMID 6692471.
“Global regulation of nucleotide biosynthetic genes by c-Myc”. PLOS One 3 (7): e2722. (July 2008). Bibcode:2008PLoSO...3.2722L. doi:10.1371/journal.pone.0002722. PMC 2444028. PMID 18628958.
“Direct role of nucleotide metabolism in C-MYC-dependent proliferation of melanoma cells”. Cell Cycle 7 (15): 2392–400. (August 2008). doi:10.4161/cc.6390. PMC 3744895. PMID 18677108.
“The Interplay between Myc and CTP Synthase in Drosophila”. PLOS Genetics 12 (2): e1005867. (February 2016). doi:10.1371/journal.pgen.1005867. PMC 4759343. PMID 26889675.
“Myc-driven endogenous cell competition in the early mammalian embryo”. Nature 500 (7460): 39–44. (August 2013). Bibcode:2013Natur.500...39C. doi:10.1038/nature12389. PMID 23842495.
“Analysis of C-MYC function in normal cells via conditional gene-targeted mutation”. Immunity 14 (1): 45–55. (January 2001). doi:10.1016/S1074-7613(01)00088-7. PMID 11163229.
“Myc-nick: a cytoplasmic cleavage product of Myc that promotes alpha-tubulin acetylation and cell differentiation”. Cell 142 (3): 480–93. (August 2010). doi:10.1016/j.cell.2010.06.037. PMC 2923036. PMID 20691906.
“c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells”. Cell 151 (1): 68–79. (September 2012). doi:10.1016/j.cell.2012.08.033. PMC 3471363. PMID 23021216.
“A SUMOylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis”. Science 335 (6066): 348–53. (January 2012). Bibcode:2012Sci...335..348K. doi:10.1126/science.1212728. PMC 4059214. PMID 22157079.
“Comprehensive genomic profiling of epithelial ovarian cancer by next generation sequencing-based diagnostic assay reveals new routes to targeted therapies”. Gynecologic Oncology 130 (3): 554–9. (September 2013). doi:10.1016/j.ygyno.2013.06.019. PMID 23791828.
“Identification of druggable cancer driver genes amplified across TCGA datasets”. PLOS One 9 (5): e98293. (2014). Bibcode:2014PLoSO...998293C. doi:10.1371/journal.pone.0098293. PMC 4038530. PMID 24874471.
“Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes”. Nature 304 (5927): 596–602. (1983). Bibcode:1983Natur.304..596L. doi:10.1038/304596a0. PMID 6308472.
“Tumor induction by ras and myc oncogenes in fetal and neonatal brain: modulating effects of developmental stage and retroviral dose”. Acta Neuropathologica 86 (5): 456–65. (1993). doi:10.1007/bf00228580. PMID 8310796.
“Regulation of MYC expression and differential JQ1 sensitivity in cancer cells”. PLOS One 9 (1): e87003. (2014). Bibcode:2014PLoSO...987003F. doi:10.1371/journal.pone.0087003. PMC 3900694. PMID 24466310.
“The mechanisms behind the therapeutic activity of BET bromodomain inhibition”. Molecular Cell 54 (5): 728–36. (June 2014). doi:10.1016/j.molcel.2014.05.016. PMC 4236231. PMID 24905006.
“BET bromodomain inhibition as a therapeutic strategy to target c-Myc”. Cell 146 (6): 904–17. (September 2011). doi:10.1016/j.cell.2011.08.017. PMC 3187920. PMID 21889194.
“Salivary Chromosome Analysis of the White-Facet Region of Drosophila Melanogaster”. Genetics 23 (3): 291–9. (May 1938). PMC 1209013. PMID 17246888.
“Drosophila myc regulates organ size by inducing cell competition”. Cell 117 (1): 107–16. (April 2004). doi:10.1016/S0092-8674(04)00214-4. PMID 15066286.
“Drosophila dMyc is required for ovary cell growth and endoreplication”. Development 131 (4): 775–86. (February 2004). doi:10.1242/dev.00932. PMID 14724122.
“Drosophila myc regulates cellular growth during development”. Cell 98 (6): 779–90. (September 1999). doi:10.1016/S0092-8674(00)81512-3. PMID 10499795.
Harris, A. W.; Pinkert, C. A.; Crawford, M.; Langdon, W. Y.; Brinster, R. L.; Adams, J. M. (1988-02-01). “The E mu-myc transgenic mouse. A model for high-incidence spontaneous lymphoma and leukemia of early B cells”. The Journal of Experimental Medicine 167 (2): 353–371. doi:10.1084/jem.167.2.353. ISSN 0022-1007. PMC 2188841. PMID 3258007.
Hofmann, Jeffrey W.; Zhao, Xiaoai; De Cecco, Marco; Peterson, Abigail L.; Pagliaroli, Luca; Manivannan, Jayameenakshi; Hubbard, Gene B.; Ikeno, Yuji et al. (2015-01-29). “Reduced expression of MYC increases longevity and enhances healthspan”. Cell 160 (3): 477–488. doi:10.1016/j.cell.2014.12.016. ISSN 1097-4172. PMC 4624921. PMID 25619689.
Abraham, Sheela A.; Hopcroft, Lisa E. M.; Carrick, Emma; Drotar, Mark E.; Dunn, Karen; Williamson, Andrew J. K.; Korfi, Koorosh; Baquero, Pablo et al. (06 16, 2016). “Dual targeting of p53 and c-MYC selectively eliminates leukaemic stem cells”. Nature 534 (7607): 341–346. doi:10.1038/nature18288. ISSN 1476-4687. PMC 4913876. PMID 27281222.
Takahaski, Kazutoshi; Yamanaka, Shinya (17 Feb 2016). “A decade of transcription factor-mediated reprogramming to pluripotency”. Nature Reviews. Molecular Cell Biology 17 (3): 183–193. doi:10.1038/nrm.2016.8. PMID 26883003.
“BAF53 forms distinct nuclear complexes and functions as a critical c-Myc-interacting nuclear cofactor for oncogenic transformation”. Molecular and Cellular Biology 22 (5): 1307–16. (March 2002). doi:10.1128/mcb.22.5.1307-1316.2002. PMC 134713. PMID 11839798.
“A novel tricomplex of BRCA1, Nmi, and c-Myc inhibits c-Myc-induced human telomerase reverse transcriptase gene (hTERT) promoter activity in breast cancer”. The Journal of Biological Chemistry 277 (23): 20965–73. (June 2002). doi:10.1074/jbc.M112231200. PMID 11916966.
“BRCA1 inhibition of telomerase activity in cultured cells”. Molecular and Cellular Biology 23 (23): 8668–90. (December 2003). doi:10.1128/mcb.23.23.8668-8690.2003. PMC 262673. PMID 14612409.
“Inhibition of human telomerase reverse transcriptase gene expression by BRCA1 in human ovarian cancer cells”. Biochemical and Biophysical Research Communications 303 (1): 130–6. (March 2003). doi:10.1016/s0006-291x(03)00318-8. PMID 12646176.
“BRCA1 binds c-Myc and inhibits its transcriptional and transforming activity in cells”. Oncogene 17 (15): 1939–48. (October 1998). doi:10.1038/sj.onc.1202403. PMID 9788437.
“Tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone promotes functional cooperation of Bcl2 and c-Myc through phosphorylation in regulating cell survival and proliferation”. The Journal of Biological Chemistry 279 (38): 40209–19. (September 2004). doi:10.1074/jbc.M404056200. PMID 15210690.
“c-Myc recruits P-TEFb for transcription, cellular proliferation and apoptosis”. Oncogene 22 (36): 5707–11. (August 2003). doi:10.1038/sj.onc.1206800. PMID 12944920.
“BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors”. Journal of Proteomics 118 (12): 95–111. (April 2015). doi:10.1016/j.jprot.2014.09.029. PMID 25452129.
“Myc represses transcription through recruitment of DNA methyltransferase corepressor”. The EMBO Journal 24 (2): 336–46. (January 2005). doi:10.1038/sj.emboj.7600509. PMC 545804. PMID 15616584.
“The p400 complex is an essential E1A transformation target”. Cell 106 (3): 297–307. (August 2001). doi:10.1016/s0092-8674(01)00450-0. PMID 11509179.
“Direct role for Myc in transcription initiation mediated by interactions with TFII-I”. Nature 365 (6444): 359–61. (September 1993). Bibcode:1993Natur.365..359R. doi:10.1038/365359a0. PMID 8377829.
“MYC recruits the TIP60 histone acetyltransferase complex to chromatin”. EMBO Reports 4 (6): 575–80. (June 2003). doi:10.1038/sj.embor.embor861. PMC 1319201. PMID 12776177.
“Widespread microRNA repression by Myc contributes to tumorigenesis”. Nature Genetics 40 (1): 43–50. (January 2008). doi:10.1038/ng.2007.30. PMC 2628762. PMID 18066065.
“Prediction and preliminary validation of oncogene regulation by miRNAs”. BMC Molecular Biology 8: 79. (2007). doi:10.1186/1471-2199-8-79. PMC 2096627. PMID 17877811.
“CRD-BP/IMP1 expression characterizes cord blood CD34+ stem cells and affects c-myc and IGF-II expression in MCF-7 cancer cells”. The Journal of Biological Chemistry 280 (20): 20086–93. (May 2005). doi:10.1074/jbc.M410036200. PMID 15769738.
“MAP kinase binds to the NH2-terminal activation domain of c-Myc”. FEBS Letters 353 (3): 281–5. (October 1994). doi:10.1016/0014-5793(94)01052-8. PMID 7957875.
“Mitogen-activated protein kinase kinase 7 is an activator of the c-Jun NH2-terminal kinase”. Proceedings of the National Academy of Sciences of the United States of America 94 (14): 7337–42. (July 1997). Bibcode:1997PNAS...94.7337T. doi:10.1073/pnas.94.14.7337. PMC 23822. PMID 9207092.
“Regulation of c-Myc through phosphorylation at Ser-62 and Ser-71 by c-Jun N-terminal kinase”. The Journal of Biological Chemistry 274 (46): 32580–7. (November 1999). doi:10.1074/jbc.274.46.32580. PMID 10551811.
“Large-scale mapping of human protein-protein interactions by mass spectrometry”. Molecular Systems Biology 3: 89. (2007). doi:10.1038/msb4100134. PMC 1847948. PMID 17353931.
“The essential cofactor TRRAP recruits the histone acetyltransferase hGCN5 to c-Myc”. Molecular and Cellular Biology 20 (2): 556–62. (January 2000). doi:10.1128/mcb.20.2.556-562.2000. PMC 85131. PMID 10611234.
“The novel ATM-related protein TRRAP is an essential cofactor for the c-Myc and E2F oncoproteins”. Cell 94 (3): 363–74. (August 1998). doi:10.1016/s0092-8674(00)81479-8. PMID 9708738.
“c-MYC interacts with INI1/hSNF5 and requires the SWI/SNF complex for transactivation function”. Nature Genetics 22 (1): 102–5. (May 1999). doi:10.1038/8811. PMID 10319872.
“Interactions of the DNA mismatch repair proteins MLH1 and MSH2 with c-MYC and MAX”. Oncogene 22 (6): 819–25. (February 2003). doi:10.1038/sj.onc.1206252. PMID 12584560.
“Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc”. Science 251 (4998): 1211–7. (March 1991). Bibcode:1991Sci...251.1211B. doi:10.1126/science.2006410. PMID 2006410.
“JLP: A scaffolding protein that tethers JNK/p38MAPK signaling modules and transcription factors”. Proceedings of the National Academy of Sciences of the United States of America 99 (22): 14189–94. (October 2002). Bibcode:2002PNAS...9914189L. doi:10.1073/pnas.232310199. PMC 137859. PMID 12391307.
“Mlx, a novel Max-like BHLHZip protein that interacts with the Max network of transcription factors”. The Journal of Biological Chemistry 274 (51): 36344–50. (December 1999). doi:10.1074/jbc.274.51.36344. PMID 10593926.
“Mmip1: a novel leucine zipper protein that reverses the suppressive effects of Mad family members on c-myc”. Oncogene 16 (9): 1149–59. (March 1998). doi:10.1038/sj.onc.1201634. PMID 9528857.
“Rox, a novel bHLHZip protein expressed in quiescent cells that heterodimerizes with Max, binds a non-canonical E box and acts as a transcriptional repressor”. The EMBO Journal 16 (10): 2892–906. (May 1997). doi:10.1093/emboj/16.10.2892. PMC 1169897. PMID 9184233.
“X-ray structures of Myc-Max and Mad-Max recognizing DNA. Molecular bases of regulation by proto-oncogenic transcription factors”. Cell 112 (2): 193–205. (January 2003). doi:10.1016/s0092-8674(02)01284-9. PMID 12553908.
“Differential effects of the widely expressed dMax splice variant of Max on E-box vs initiator element-mediated regulation by c-Myc”. Oncogene 18 (15): 2489–98. (April 1999). doi:10.1038/sj.onc.1202611. PMID 10229200.
“Mlx, a new Max-like bHLHZip family member: the center stage of a novel transcription factors regulatory pathway?”. Oncogene 19 (29): 3266–77. (July 2000). doi:10.1038/sj.onc.1203634. PMID 10918583.
“Identification of a large Myc-binding protein that contains RCC1-like repeats”. Proceedings of the National Academy of Sciences of the United States of America 95 (16): 9172–7. (August 1998). Bibcode:1998PNAS...95.9172G. doi:10.1073/pnas.95.16.9172. PMC 21311. PMID 9689053.
“AMY-1, a novel C-MYC binding protein that stimulates transcription activity of C-MYC”. Genes to Cells 3 (8): 549–65. (August 1998). doi:10.1046/j.1365-2443.1998.00206.x. PMID 9797456.
“Mechanism for the transcriptional repression by c-Myc on PDGF beta-receptor”. Journal of Cell Science 114 (Pt 8): 1533–44. (April 2001). PMID 11282029.
“Cell cycle-dependent switch of up-and down-regulation of human hsp70 gene expression by interaction between c-Myc and CBF/NF-Y”. The Journal of Biological Chemistry 274 (34): 24270–9. (August 1999). doi:10.1074/jbc.274.34.24270. PMID 10446203.
“p73 Interacts with c-Myc to regulate Y-box-binding protein-1 expression”. The Journal of Biological Chemistry 277 (35): 31694–702. (August 2002). doi:10.1074/jbc.M200266200. PMID 12080043.
“c-Myc transformation domain recruits the human STAGA complex and requires TRRAP and GCN5 acetylase activity for transcription activation”. The Journal of Biological Chemistry 278 (22): 20405–12. (May 2003). doi:10.1074/jbc.M211795200. PMC 4031917. PMID 12660246.
“MM-1, a novel c-Myc-associating protein that represses transcriptional activity of c-Myc”. The Journal of Biological Chemistry 273 (45): 29794–800. (November 1998). doi:10.1074/jbc.273.45.29794. PMID 9792694.
“MM-1, a c-Myc-binding protein, is a candidate for a tumor suppressor in leukemia/lymphoma and tongue cancer”. The Journal of Biological Chemistry 276 (48): 45137–44. (November 2001). doi:10.1074/jbc.M106127200. PMID 11567024.
“Direct interaction of c-Myc with Smad2 and Smad3 to inhibit TGF-beta-mediated induction of the CDK inhibitor p15(Ink4B)”. Molecular Cell 9 (1): 133–43. (January 2002). doi:10.1016/s1097-2765(01)00430-0. PMID 11804592.
“Guanine nucleotide exchange factor, Tiam1, directly binds to c-Myc and interferes with c-Myc-mediated apoptosis in rat-1 fibroblasts”. The Journal of Biological Chemistry 278 (7): 5132–40. (February 2003). doi:10.1074/jbc.M206733200. PMID 12446731.
“Transcriptional activation by Myc is under negative control by the transcription factor AP-2”. The EMBO Journal 14 (7): 1508–19. (April 1995). doi:10.1002/j.1460-2075.1995.tb07137.x. PMC 398238. PMID 7729426.
“Interaction with WDR5 promotes target gene recognition and tumorigenesis by MYC”. Molecular Cell 58 (3): 440–52. (May 2015). doi:10.1016/j.molcel.2015.02.028. PMC 4427524. PMID 25818646.
“Inhibition of transcriptional regulator Yin-Yang-1 by association with c-Myc”. Science 262 (5141): 1889–92. (December 1993). Bibcode:1993Sci...262.1889S. doi:10.1126/science.8266081. PMID 8266081.
“Repression of p15INK4b expression by Myc through association with Miz-1”. Nature Cell Biology 3 (4): 392–9. (April 2001). doi:10.1038/35070076. PMID 11283613.
“An alternative pathway for gene regulation by Myc”. The EMBO Journal 16 (18): 5672–86. (September 1997). doi:10.1093/emboj/16.18.5672. PMC 1170199. PMID 9312026.

ncbi.nlm.nih.gov

“Myc”. NCBI. 2020年6月24日閲覧。
“Sequence analysis of the Myc oncogene involved in the t(8;14)(q24;q11) chromosome translocation in a human leukemia T-cell line indicates that putative regulatory regions are not altered”. Proceedings of the National Academy of Sciences of the United States of America 85 (9): 3052–6. (May 1988). Bibcode:1988PNAS...85.3052F. doi:10.1073/pnas.85.9.3052. PMC 280141. PMID 2834731.
“Therapeutic Inhibition of Myc in Cancer. Structural Bases and Computer-Aided Drug Discovery Approaches”. International Journal of Molecular Sciences 20 (1): 120. (December 2018). doi:10.3390/ijms20010120. PMC 6337544. PMID 30597997.
“Drugging the 'undruggable' cancer targets”. Nature Reviews. Cancer 17 (8): 502–508. (August 2017). doi:10.1038/nrc.2017.36. PMC 5945194. PMID 28643779.
“N-Myc regulates a widespread euchromatic program in the human genome partially independent of its role as a classical transcription factor”. Cancer Research 68 (23): 9654–62. (December 2008). doi:10.1158/0008-5472.CAN-08-1961. PMC 2637654. PMID 19047142.
Wasylishen, Amanda R.; Penn, Linda Z. (2010-06). “Myc: the beauty and the beast”. Genes & Cancer 1 (6): 532–541. doi:10.1177/1947601910378024. ISSN 1947-6027. PMC 3092215. PMID 21779457.
Stoneley, M.; Subkhankulova, T.; Le Quesne, J. P.; Coldwell, M. J.; Jopling, C. L.; Belsham, G. J.; Willis, A. E. (2000-02-01). “Analysis of the c-myc IRES; a potential role for cell-type specific trans-acting factors and the nuclear compartment”. Nucleic Acids Research 28 (3): 687–694. doi:10.1093/nar/28.3.687. ISSN 1362-4962. PMC 102558. PMID 10637319.
“MYC and transcription elongation”. Cold Spring Harbor Perspectives in Medicine 4 (1): a020990. (January 2014). doi:10.1101/cshperspect.a020990. PMC 3869279. PMID 24384817.
“Global regulation of nucleotide biosynthetic genes by c-Myc”. PLOS One 3 (7): e2722. (July 2008). Bibcode:2008PLoSO...3.2722L. doi:10.1371/journal.pone.0002722. PMC 2444028. PMID 18628958.
“Direct role of nucleotide metabolism in C-MYC-dependent proliferation of melanoma cells”. Cell Cycle 7 (15): 2392–400. (August 2008). doi:10.4161/cc.6390. PMC 3744895. PMID 18677108.
“The Interplay between Myc and CTP Synthase in Drosophila”. PLOS Genetics 12 (2): e1005867. (February 2016). doi:10.1371/journal.pgen.1005867. PMC 4759343. PMID 26889675.
“Myc-nick: a cytoplasmic cleavage product of Myc that promotes alpha-tubulin acetylation and cell differentiation”. Cell 142 (3): 480–93. (August 2010). doi:10.1016/j.cell.2010.06.037. PMC 2923036. PMID 20691906.
“c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells”. Cell 151 (1): 68–79. (September 2012). doi:10.1016/j.cell.2012.08.033. PMC 3471363. PMID 23021216.
“A SUMOylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis”. Science 335 (6066): 348–53. (January 2012). Bibcode:2012Sci...335..348K. doi:10.1126/science.1212728. PMC 4059214. PMID 22157079.
“Identification of druggable cancer driver genes amplified across TCGA datasets”. PLOS One 9 (5): e98293. (2014). Bibcode:2014PLoSO...998293C. doi:10.1371/journal.pone.0098293. PMC 4038530. PMID 24874471.
“Regulation of MYC expression and differential JQ1 sensitivity in cancer cells”. PLOS One 9 (1): e87003. (2014). Bibcode:2014PLoSO...987003F. doi:10.1371/journal.pone.0087003. PMC 3900694. PMID 24466310.
“The mechanisms behind the therapeutic activity of BET bromodomain inhibition”. Molecular Cell 54 (5): 728–36. (June 2014). doi:10.1016/j.molcel.2014.05.016. PMC 4236231. PMID 24905006.
“BET bromodomain inhibition as a therapeutic strategy to target c-Myc”. Cell 146 (6): 904–17. (September 2011). doi:10.1016/j.cell.2011.08.017. PMC 3187920. PMID 21889194.
“Salivary Chromosome Analysis of the White-Facet Region of Drosophila Melanogaster”. Genetics 23 (3): 291–9. (May 1938). PMC 1209013. PMID 17246888.
Harris, A. W.; Pinkert, C. A.; Crawford, M.; Langdon, W. Y.; Brinster, R. L.; Adams, J. M. (1988-02-01). “The E mu-myc transgenic mouse. A model for high-incidence spontaneous lymphoma and leukemia of early B cells”. The Journal of Experimental Medicine 167 (2): 353–371. doi:10.1084/jem.167.2.353. ISSN 0022-1007. PMC 2188841. PMID 3258007.
Hofmann, Jeffrey W.; Zhao, Xiaoai; De Cecco, Marco; Peterson, Abigail L.; Pagliaroli, Luca; Manivannan, Jayameenakshi; Hubbard, Gene B.; Ikeno, Yuji et al. (2015-01-29). “Reduced expression of MYC increases longevity and enhances healthspan”. Cell 160 (3): 477–488. doi:10.1016/j.cell.2014.12.016. ISSN 1097-4172. PMC 4624921. PMID 25619689.
Abraham, Sheela A.; Hopcroft, Lisa E. M.; Carrick, Emma; Drotar, Mark E.; Dunn, Karen; Williamson, Andrew J. K.; Korfi, Koorosh; Baquero, Pablo et al. (06 16, 2016). “Dual targeting of p53 and c-MYC selectively eliminates leukaemic stem cells”. Nature 534 (7607): 341–346. doi:10.1038/nature18288. ISSN 1476-4687. PMC 4913876. PMID 27281222.
“BAF53 forms distinct nuclear complexes and functions as a critical c-Myc-interacting nuclear cofactor for oncogenic transformation”. Molecular and Cellular Biology 22 (5): 1307–16. (March 2002). doi:10.1128/mcb.22.5.1307-1316.2002. PMC 134713. PMID 11839798.
“BRCA1 inhibition of telomerase activity in cultured cells”. Molecular and Cellular Biology 23 (23): 8668–90. (December 2003). doi:10.1128/mcb.23.23.8668-8690.2003. PMC 262673. PMID 14612409.
“Myc represses transcription through recruitment of DNA methyltransferase corepressor”. The EMBO Journal 24 (2): 336–46. (January 2005). doi:10.1038/sj.emboj.7600509. PMC 545804. PMID 15616584.
“MYC recruits the TIP60 histone acetyltransferase complex to chromatin”. EMBO Reports 4 (6): 575–80. (June 2003). doi:10.1038/sj.embor.embor861. PMC 1319201. PMID 12776177.
“Widespread microRNA repression by Myc contributes to tumorigenesis”. Nature Genetics 40 (1): 43–50. (January 2008). doi:10.1038/ng.2007.30. PMC 2628762. PMID 18066065.
“Prediction and preliminary validation of oncogene regulation by miRNAs”. BMC Molecular Biology 8: 79. (2007). doi:10.1186/1471-2199-8-79. PMC 2096627. PMID 17877811.
“Mitogen-activated protein kinase kinase 7 is an activator of the c-Jun NH2-terminal kinase”. Proceedings of the National Academy of Sciences of the United States of America 94 (14): 7337–42. (July 1997). Bibcode:1997PNAS...94.7337T. doi:10.1073/pnas.94.14.7337. PMC 23822. PMID 9207092.
“Large-scale mapping of human protein-protein interactions by mass spectrometry”. Molecular Systems Biology 3: 89. (2007). doi:10.1038/msb4100134. PMC 1847948. PMID 17353931.
“The essential cofactor TRRAP recruits the histone acetyltransferase hGCN5 to c-Myc”. Molecular and Cellular Biology 20 (2): 556–62. (January 2000). doi:10.1128/mcb.20.2.556-562.2000. PMC 85131. PMID 10611234.
“JLP: A scaffolding protein that tethers JNK/p38MAPK signaling modules and transcription factors”. Proceedings of the National Academy of Sciences of the United States of America 99 (22): 14189–94. (October 2002). Bibcode:2002PNAS...9914189L. doi:10.1073/pnas.232310199. PMC 137859. PMID 12391307.
“Rox, a novel bHLHZip protein expressed in quiescent cells that heterodimerizes with Max, binds a non-canonical E box and acts as a transcriptional repressor”. The EMBO Journal 16 (10): 2892–906. (May 1997). doi:10.1093/emboj/16.10.2892. PMC 1169897. PMID 9184233.
“Identification of a large Myc-binding protein that contains RCC1-like repeats”. Proceedings of the National Academy of Sciences of the United States of America 95 (16): 9172–7. (August 1998). Bibcode:1998PNAS...95.9172G. doi:10.1073/pnas.95.16.9172. PMC 21311. PMID 9689053.
“c-Myc transformation domain recruits the human STAGA complex and requires TRRAP and GCN5 acetylase activity for transcription activation”. The Journal of Biological Chemistry 278 (22): 20405–12. (May 2003). doi:10.1074/jbc.M211795200. PMC 4031917. PMID 12660246.
“Transcriptional activation by Myc is under negative control by the transcription factor AP-2”. The EMBO Journal 14 (7): 1508–19. (April 1995). doi:10.1002/j.1460-2075.1995.tb07137.x. PMC 398238. PMID 7729426.
“Interaction with WDR5 promotes target gene recognition and tumorigenesis by MYC”. Molecular Cell 58 (3): 440–52. (May 2015). doi:10.1016/j.molcel.2015.02.028. PMC 4427524. PMID 25818646.
“An alternative pathway for gene regulation by Myc”. The EMBO Journal 16 (18): 5672–86. (September 1997). doi:10.1093/emboj/16.18.5672. PMC 1170199. PMID 9312026.

pmc.ncbi.nlm.nih.gov

reuters.com (Global: 38^th place; Japanese: 68^th place)

Begley S (2013年1月9日). “DNA pioneer James Watson takes aim at cancer establishments”. Reuters. 2020年6月24日閲覧。

uzh.ch (Global: 1,380^th place; Japanese: 9,870^th place)

zora.uzh.ch

“Drosophila myc regulates cellular growth during development”. Cell 98 (6): 779–90. (September 1999). doi:10.1016/S0092-8674(00)81512-3. PMID 10499795.

worldcat.org (Global: 4^th place; Japanese: 12^th place)

search.worldcat.org

Wasylishen, Amanda R.; Penn, Linda Z. (2010-06). “Myc: the beauty and the beast”. Genes & Cancer 1 (6): 532–541. doi:10.1177/1947601910378024. ISSN 1947-6027. PMC 3092215. PMID 21779457.
Lüscher, B.; Larsson, L. G. (1999-05-13). “The basic region/helix-loop-helix/leucine zipper domain of Myc proto-oncoproteins: function and regulation”. Oncogene 18 (19): 2955–2966. doi:10.1038/sj.onc.1202750. ISSN 0950-9232. PMID 10378692.
Stoneley, M.; Subkhankulova, T.; Le Quesne, J. P.; Coldwell, M. J.; Jopling, C. L.; Belsham, G. J.; Willis, A. E. (2000-02-01). “Analysis of the c-myc IRES; a potential role for cell-type specific trans-acting factors and the nuclear compartment”. Nucleic Acids Research 28 (3): 687–694. doi:10.1093/nar/28.3.687. ISSN 1362-4962. PMC 102558. PMID 10637319.
Harris, A. W.; Pinkert, C. A.; Crawford, M.; Langdon, W. Y.; Brinster, R. L.; Adams, J. M. (1988-02-01). “The E mu-myc transgenic mouse. A model for high-incidence spontaneous lymphoma and leukemia of early B cells”. The Journal of Experimental Medicine 167 (2): 353–371. doi:10.1084/jem.167.2.353. ISSN 0022-1007. PMC 2188841. PMID 3258007.
Hofmann, Jeffrey W.; Zhao, Xiaoai; De Cecco, Marco; Peterson, Abigail L.; Pagliaroli, Luca; Manivannan, Jayameenakshi; Hubbard, Gene B.; Ikeno, Yuji et al. (2015-01-29). “Reduced expression of MYC increases longevity and enhances healthspan”. Cell 160 (3): 477–488. doi:10.1016/j.cell.2014.12.016. ISSN 1097-4172. PMC 4624921. PMID 25619689.
Abraham, Sheela A.; Hopcroft, Lisa E. M.; Carrick, Emma; Drotar, Mark E.; Dunn, Karen; Williamson, Andrew J. K.; Korfi, Koorosh; Baquero, Pablo et al. (06 16, 2016). “Dual targeting of p53 and c-MYC selectively eliminates leukaemic stem cells”. Nature 534 (7607): 341–346. doi:10.1038/nature18288. ISSN 1476-4687. PMC 4913876. PMID 27281222.